(Q46952395)

English

Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet) versus calcipotriol (Daivonex) in the treatment of psoriasis vulgaris: a randomized, multicentre, clinical trial

scientific article published in January 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17934937

Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet) versus calcipotriol (Daivonex) in the treatment of psoriasis vulgaris: a randomized, multicentre, clinical trial (English)

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17934937

multicenter clinical trial

1 reference

based on heuristic

inferred from title

quality of life

1 reference

based on heuristic

inferred from title

Maria Rita Bongiorno

4

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17934937

8

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17934937

6

object named as

Paolo Lisi

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17934937

Sergio Chimenti

10

object named as

Sergio Chimenti

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17934937

author name string

Rosita Saraceno

1

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17934937

Lucio Andreassi

2

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17934937

Fablo Ayala

3

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17934937

Alberto Giannetti

5

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17934937

Patrizia Martini

7

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17934937

Andrea Peserico

9

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17934937

publication date

1 January 2007

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17934937

Journal of Dermatological Treatment

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17934937

18

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17934937

6

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17934937

361-365

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17934937

Novel therapies for psoriasis

1 reference

https://api.crossref.org/works/10.1080%2F09546630701646156

21 January 2018

Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical tria

1 reference

https://api.crossref.org/works/10.1080%2F09546630701646156

21 January 2018

Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis

1 reference

https://api.crossref.org/works/10.1080%2F09546630701646156

21 January 2018

A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris

1 reference

https://api.crossref.org/works/10.1080%2F09546630701646156

21 January 2018

The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F09546630701646156

21 January 2018

Efficacy of treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol for the treatment of psoriasis vulgaris: a randomised, double-blind trial

1 reference

https://api.crossref.org/works/10.1080%2F09546630701646156

21 January 2018

Calcipotriol cream in the morning and ointment in the evening: a novel regimen to improve compliance

1 reference

https://api.crossref.org/works/10.1080%2F09546630701646156

21 January 2018

Topical use of calcitriol 3 microg/g ointment in the treatment of mild-to-moderate psoriasis: results from an open-label study

1 reference

https://api.crossref.org/works/10.1080%2F09546630701646156

21 January 2018

Further evidence of the validity and reliability of the Skindex-29: an Italian study on 2,242 dermatological outpatients

1 reference

https://api.crossref.org/works/10.1080%2F09546630701646156

21 January 2018

Identifiers

10.1080/09546630701646156

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17934937

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17934937

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46952395&oldid=2139479884"